First in Human Study to Compare Safety Between Intravenous Bolus Versus Infusion of ApTOLL
Clinical trial NCT05569720 · COMPLETED
Trial details
- NCT number
- NCT05569720
- Sponsor
- aptaTargets S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-25
- Primary completion
- 2022-06-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.